Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO 18 U.S.C - TANDEM DIABETES CARE INC | tndm-ex322_6.htm |
| EX-32.1 - CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. - TANDEM DIABETES CARE INC | tndm-ex321_8.htm |
| EX-31.2 - CERTIFICATION OF CFO PER SARBANES-OXLEY ACT - TANDEM DIABETES CARE INC | tndm-ex312_9.htm |
| EX-31.1 - CERTIFICATION OF CEO PER SARBANES-OXLEY ACT - TANDEM DIABETES CARE INC | tndm-ex311_7.htm |
| 10-K - 10-K TNDM 2017 - TANDEM DIABETES CARE INC | tndm-10k_20171231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-333-222143) of Tandem Diabetes Care, Inc.,
(2) Registration Statement (Form S-8 No. 333-192406) pertaining to the 2006 Stock Incentive Plan, 2013 Stock Incentive Plan, and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc.,
(3) Registration Statement (Form S-8 No. 333-202254) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc., and
(4) Registration Statement (Form S-8 No. 333-209685) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc.;
of our report dated March 1, 2018, with respect to the financial statements of Tandem Diabetes Care, Inc. included in this Annual Report (Form 10-K) of Tandem Diabetes Care, Inc. for the year ended December 31, 2017.
/s/Ernst & Young LLP
San Diego, California
March 1, 2018